Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
CALL
Innoviz Technologies
INVZ
$84.1M
| $2.47M | ﹤0.01% |
2,665,000
+1,461,200
| +121% | +$1.64M |
|
2102
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.47M | ﹤0.01% |
+30,000
| New | +$2.5M |
|
|
2103
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.47M | ﹤0.01% |
+30,000
| New | +$2.5M |
|
2104
Korn Ferry
KFY
$4.31B
| $2.47M | ﹤0.01% |
36,782
-1,025
| -3% | -$65.9K |
|
2105
CALL
ARK Genomic Revolution ETF
ARKG
$1.53B
| $2.47M | ﹤0.01% |
+105,000
| New | +$2.65M |
|
|
X
2106
DELISTED
US Steel
X
| $2.46M | ﹤0.01% |
65,166
-64,264
| -50% | -$2.45M |
|
2107
Renasant Corp
RNST
$4.04B
| $2.46M | ﹤0.01% |
80,533
+1,620
| +2% | +$48.2K |
|
|
TERN
2108
DELISTED
Terns Pharmaceuticals
TERN
| $2.46M | ﹤0.01% |
361,080
+203,519
| +129% | +$1.23M |
|
|
SIX
2109
DELISTED
Six Flags Entertainment Corp.
SIX
| $2.45M | ﹤0.01% |
74,072
-1,434
| -2% | -$37.8K |
|
2110
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $2.45M | ﹤0.01% |
24,670
-1,335
| -5% | -$132K |
|
2111
Ryan Specialty Holdings
RYAN
$6.02B
| $2.45M | ﹤0.01% |
42,349
+9,178
| +28% | +$490K |
|
2112
Atour Lifestyle Holdings
ATAT
$4.81B
| $2.45M | ﹤0.01% |
133,384
+98,812
| +286% | +$1.78M |
|
2113
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $2.45M | ﹤0.01% |
31,642
-145,251
| -82% | -$11.2M |
|
2114
Integra LifeSciences
IART
$1.28B
| $2.44M | ﹤0.01% |
83,768
-475
| -0.6% | -$14.1K |
|
2115
Assured Guaranty
AGO
$3.73B
| $2.44M | ﹤0.01% |
31,599
-1,391
| -4% | -$109K |
|
2116
Shake Shack
SHAK
$2.54B
| $2.43M | ﹤0.01% |
27,047
+3,434
| +15% | +$335K |
|
2117
CALL
Revolution Medicines
RVMD
$38.5B
| $2.43M | ﹤0.01% |
62,600
+41,600
| +198% | +$1.55M |
|
2118
Intellia Therapeutics
NTLA
$1.51B
| $2.43M | ﹤0.01% |
108,382
-234,584
| -68% | -$5.59M |
|
|
NKLA
2119
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $2.43M | ﹤0.01% |
296,106
-84,947
| -22% | -$1.52M |
|
2120
Chewy
CHWY
$9.54B
| $2.42M | ﹤0.01% |
88,794
-13,761
| -13% | -$262K |
|
2121
Artisan Partners
APAM
$2.86B
| $2.41M | ﹤0.01% |
58,495
+5,093
| +10% | +$220K |
|
2122
iShares Core S&P US Value ETF
IUSV
$27.3B
| $2.41M | ﹤0.01% |
27,351
+5,382
| +24% | +$474K |
|
2123
CALL
Ciena
CIEN
$46.8B
| $2.41M | ﹤0.01% |
50,000
| – | – |
|
2124
Blackstone Mortgage Trust
BXMT
$2.77B
| $2.4M | ﹤0.01% |
137,550
-32,727
| -19% | -$591K |
|
2125
Liberty Energy
LBRT
$2.79B
| $2.4M | ﹤0.01% |
114,676
+10,621
| +10% | +$237K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.